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Summary Abstract 
 
Healthcare organisations have important roles in society in terms of safeguarding and 
promoting public health. Considering the healthcare organisations’ crucial role and the 
fact that they face the challenge of minimising the cost of healthcare services while 
enhancing service quality, healthcare organisations tend to adopt various improvement 
approaches and innovative interventions to enhance their efficiency and effectiveness. 
This research evaluates the implementation of innovative programmes within 
Pharmaceutical Supply Chains (PSC). It aims to assess the current medicine delivery 
process and identify the factors that affect the perceived innovation level within the PSC 
in two diverse European contexts. 
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Purpose  
Healthcare organisations have important roles, in society, in promoting public health. 
Particularly, hospital and community pharmacies are considered as the link between 
healthcare services and patients because they are responsible for dispensing 
pharmaceuticals in order to prolong healthy life (Westrick and Mount, 2009). 
Considering the healthcare organisations’ crucial role and the fact that they face the 
challenge of minimising the cost of healthcare services, whilst enhancing service 
quality, healthcare organisations tend to adopt multiple improvement approaches and 
innovative interventions to increase their efficiency and effectiveness (Brandao de 
Souza, 2009). They implement innovative programmes in order to be able to provide 
high quality services whilst using the same or similar level of resources (Cheng et al., 
2015).  Specifically, they focus on improving their Supply Chain Management (SCM) 
in order to reduce any type of waste and in particular their drugs spending to provide 
better services (Kearney, 2009). However, Bamford et al., (2015) found that these 
approaches remain patchy and methodologically limited in this sector. 
The reform agenda in healthcare refers to innovation as a source of concern 
(Williams, 2011). Innovation is identified as the intentional introduction of new or 
significantly improved services, processes or products within the organisation in order 
to benefit it and the wider society (Omachonu and Einspruch, 2010). Literature indicates 
that innovation in the healthcare sector is considered to lag behind those in non-
healthcare sectors (Liddell et al., 2008). This might be due to successful implementation 
of innovative programmes depending upon the organisational context. In particular, 
healthcare organisations are generally characterised as centralised organisations 
(Bamford, 2011) which could explain the slow uptake of innovation (Grol and Wensing, 
2004), fragmentation in commissioning and procurement practices (Williams, 2011) and 
the sub-optional use of guidance (Liddell et al., 2008). 
This research identifies the factors that support or prevent innovation within this 
complex environment. In particular, the factors under consideration reflect the time to 
respond to customers/suppliers, staff communication, staff/patients satisfaction, 
economic risk, cost of innovation, lack of finance, access to information and 
external/internal collaboration. The innovation level is approached by means of 
new/improved products/services introduction. To test the relationship between the study 
variables, the following hypotheses were established:  
H1: Time to respond to customers/suppliers (a), staff communication (b) and 
staff/patients satisfaction (c) are positively related to the innovation level when 
considering the introduction of new/improved products/services. 
H2: Economic risk (a), cost of innovation (b) and lack of finance (c) are negatively 
related to the innovation level when considering introduction of new/improved 
products/services. 
H3: Access to information (a) and external/internal collaboration (b) are positively 
related to the innovation level when considering the introduction of new/improved 
products/services. 
  
Design/methodology/approach  
A quantitative approach was adopted to identify the factors that affect the innovation 
level in the PSC. Particularly, the research emphasises on investigating the current 
pharmaceutical delivery practices adopted and implemented in two specific European 
contexts: the UK and Greece. Although these two countries are member of the European 
Union (EU) and, thus, have to follow the same large body of legislation related to the 
delivery of medicines, there are some significant differences between these two 
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locations that might influence pharmacies decision to innovate. These differences are 
related to the countries’ size; the available financial resources; the healthcare systems 
applied and the impact of the on-going economic recession. We, therefore, were 
interested in exploring the complex delivery system into these diverse contexts. 
    The analysis of the collected quantitative data enabled the researcher to identify the 
factors that affect the pharmacies’ innovativeness in the two selected geographical areas 
and perhaps in the wider Europe. The sample (N=130) consisted of 81 specialists 
working within the PSC in Greece while the remaining (38%) were located in the UK. 
An online survey was used to collect the required data.  The questionnaire included 13 
items rated on a 5-point Likert scale. 
  
Findings  
Figure 1 illustrates the output of the quantitative analysis, using SPSS version 20.0.  
 
 
Note. Dashed arrows represent non-significant relationships 
Figure 1 - Results - Innovation Level 
 
 
It can be summarised from Figure 1 that three factors appear to affect the level of 
innovation: economic risk, access to information and external/internal collaboration. In 
particular, H1 has been rejected as none of the aforementioned variables was 
significantly related to the innovation level; H2b and H2c has been rejected as well but 
H2a has been accepted indicating that economic risk (β = -.258, p < .05) was 
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economic risk (β = .215, p < .05) and cost of innovation (β = .221, p < .05) were 
significantly and positively related to the innovation level, therefore, H3 has been 
accepted. 
 
Relevance/contribution  
The Regression Analysis of the total sample indicates that pharmacies tend to introduce 
new or improved drug delivery services when they have enough information and the 
support of external/internal collaboration. They are very sceptical in implementing new 
or improved services when they have to invest a particular amount of money; their 
concern is related to the potential economic risk associated with such strategies. 
 The identification of the factors that influence hospital and community pharmacies’ 
innovativeness can contribute to the better understanding of the current delivery process 
practices applied within the PSC. This might enable any improvements and changes to 
be recommended in order for effective and efficient delivery system to be implemented. 
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